OpenAlex
PricingAboutJobs
Log inGet started
Work

Imatinib mesylate as treatment for blastic transformation of Philadelphia chromosome positive chronic myelogenous leukemia.

PubMed

Year: 2003
Type: article
Study design: Clinical Trial
Source: PubMed
Authors: Anna Sureda, Marina Carrasco, Miguel de Miguel, Jesùs A Martínez, Eulogio Conde, Miguel A Sanz, Joaquin Díaz-Mediavilla, Jorge Sierra
Institution: Hospital de Sant Pau
Language: English

Topic: Chronic Myeloid Leukemia Treatments
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Keywords: imatinib mesylate, imatinib, Philadelphia chromosome-positive chronic myelogenous leukemia, blast crisis, BCR-ABL tyrosine kinase inhibitors, hematologic remission, cytogenetic remission, event-free survival, overall survival, prognostic factors, time to treatment, complex karyotype, extramedullary involvement
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W2096135025
FWCI: 1.606
Cites: 21
Cited by: 48
Related to: 9
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms
Security